Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Rating) saw a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 400 shares, a decrease of 99.1% from the March 31st total of 42,900 shares. Based on an average daily volume of 187,700 shares, the short-interest ratio is […]